Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Summary

Apellis Pharmaceuticals (APLS) has announced its participation in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. The company's presentation is scheduled for Wednesday, June 11, 2025, at 10:40 a.m. ET. Investors and interested parties can access the live webcast through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website. A replay of the presentation will remain available for approximately 90 days after the event.

AI-generated analysis. Not financial advice.

News Market Reaction – APLS

-1.65%

1 alert

-1.65% News Effect

On the day this news was published, APLS declined 1.65%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46^th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact: 
Neil Carnahan
neil.carnahan@apellis.com
617.977.5703

FAQ

When is Apellis Pharmaceuticals (APLS) presenting at the Goldman Sachs Healthcare Conference 2025?

Apellis Pharmaceuticals will present at the Goldman Sachs Healthcare Conference on Wednesday, June 11, 2025, at 10:40 a.m. ET.

How can I watch Apellis Pharmaceuticals' (APLS) presentation at the Goldman Sachs conference?

The presentation can be accessed via live webcast on the 'Events and Presentations' page of the 'Investors and Media' section on Apellis' website.

How long will the replay of Apellis' Goldman Sachs conference presentation be available?

The replay of the webcast will be available for approximately 90 days following the event.

What is the Goldman Sachs Annual Global Healthcare Conference that Apellis is attending?

The Goldman Sachs Annual Global Healthcare Conference is a significant industry event where healthcare companies present to investors and analysts. This will be the 46th edition of the conference.